Published in Int J Vitam Nutr Res on January 01, 1972
Vitamin C: the known and the unknown and Goldilocks. Oral Dis (2016) 0.82
l-dehydroascorbic acid can substitute l-ascorbic acid as dietary vitamin C source in guinea pigs. Redox Biol (2015) 0.77
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences. Cell (1984) 3.61
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci U S A (2001) 2.63
CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology (2001) 2.16
High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes. Cell (1985) 2.14
[Guideline-conforming interventional treatment of acute ST-segment elevation myocardial infarction in rural areas using network collaboration]. Dtsch Med Wochenschr (2004) 2.11
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood (1994) 1.95
Simian virus 40 enhancer increases RNA polymerase density within the linked gene. Nature (1985) 1.66
Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann N Y Acad Sci (1975) 1.64
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill (2013) 1.55
Enhancer activity correlates with the oncogenic potential of avian retroviruses. EMBO J (1985) 1.52
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. Eur J Neurol (2012) 1.51
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells. Ann Neurol (1995) 1.50
Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J (1986) 1.48
[Magnetic resonance imaging of tibial periostitis]. J Radiol (1998) 1.38
Method for the detection of a biochemical riboflavin deficiency. Stimulation of NADPH2-dependent glutathione reductase from human erythrocytes by FAD in vitro. Investigations on the vitamin B2 status in healthly people and geriatric patients. Int Z Vitaminforsch (1970) 1.36
Transfer RNAs of potato (Solanum tuberosum) mitochondria have different genetic origins. Nucleic Acids Res (1990) 1.33
Mechanism of chaperonin action: GroES binding and release can drive GroEL-mediated protein folding in the absence of ATP hydrolysis. EMBO J (1996) 1.32
[A case of Goldenhar syndrome: acute vitamin A intoxication in the mother during pregnancy]. J Genet Hum (1975) 1.31
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest (1993) 1.27
Identification of 21r and 22r chromosomes by quinacrine fluorescence. Clin Genet (1972) 1.25
Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler (2004) 1.24
Redundancy of information in enhancers as a principle of mammalian transcription control. J Mol Biol (1988) 1.23
Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.19
Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell (1983) 1.16
Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assist. Br J Anaesth (2005) 1.14
Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol (2000) 1.13
Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr (1979) 1.13
A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther (1999) 1.12
Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem (1995) 1.12
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett (1996) 1.11
Essential role of vitamin C and zinc in child immunity and health. J Int Med Res (2010) 1.10
The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol. Life Sci (1981) 1.09
Glutathione reductase test with whole blood, a convenient procedure for the assessment of the riboflavin status in humans. Experientia (1974) 1.04
Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol (2007) 1.03
The fourth genus in the Orthomyxoviridae: sequence analyses of two Thogoto virus polymerase proteins and comparison with influenza viruses. Virus Res (1997) 1.03
CDI Blood Parameter Monitoring System 500--a new tool for the clinical perfusionist. J Extra Corpor Technol (2000) 1.01
Duplication 11 (q21 to 23 leads to qter) syndrome. Birth Defects Orig Artic Ser (1977) 1.01
Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol (2001) 1.00
A transcription enhancer in the Herpesvirus saimiri genome. EMBO J (1985) 0.99
[Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDS. Experience with 30 cases]. Anaesthesist (2004) 0.98
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology (1995) 0.97
Patient restraint and safety vests: minimizing the hazards. Dimens Health Serv (1981) 0.97
CT and MR imaging in neuro-Behçet disease. J Comput Assist Tomogr (1986) 0.96
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. J Neuroimmunol (2002) 0.95
An ultrasonographic study of the organisation of sucking and swallowing by newborn infants. Dev Med Child Neurol (1986) 0.95
Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone. Eur J Immunol (1993) 0.95
Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells. Brain (1994) 0.94
Enhanced influenza surveillance on Réunion Island (southern hemisphere) in the context of the emergence of influenza A(H1N1)v. Euro Surveill (2009) 0.94
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport (2000) 0.93
[EEG changes during sedation with gamma-hydroxybutyric acid]. Anaesthesist (1995) 0.93
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol (2008) 0.93
Enzymatic test for the detection of a riboflavin deficiency. NADPH-dependent glutathione reductase of red blood cells and its activation by FAD in vitro. Experientia (1968) 0.93
Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol (2001) 0.93
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler (2012) 0.92
Perception and suppression of thermally induced pain: a fMRI study. Somatosens Mot Res (2009) 0.92
Changes of telomere lengths in human intracranial tumours. Hum Genet (1993) 0.92
Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors. J Comput Aided Mol Des (1994) 0.92
Catecholamines, growth hormone, cortisol, insulin, and sex hormones in anaerobic and aerobic exercise. Eur J Appl Physiol Occup Physiol (1982) 0.92
Development of a risk index for the prediction of chronic post-surgical pain. Eur J Pain (2011) 0.91
[On the synthesis and vitamin E activity of tocopheramines and their N-alkyl derivatives]. Helv Chim Acta (1966) 0.91
Formation of virus-like particles from cloned cDNAs of Thogoto virus. J Gen Virol (2000) 0.91
Metabolism of vitamin A and the determination of vitamin A status. Vitam Horm (1974) 0.91
Autoradiographic distribution of (1- 14 C) ascorbic acid and (1- 14 C) dehydroascorbic acid in male guinea pigs after intravenous injection. Int J Vitam Nutr Res (1972) 0.91
Embolism during intrauterine laser surgery. CMAJ (1990) 0.91
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol (1996) 0.91
The interferon response circuit in antiviral host defense. Verh K Acad Geneeskd Belg (2009) 0.90
Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma. Cancer Gene Ther (2001) 0.89
Studies on the reconstitution of apotransketolase with thiamine pyrophosphate and analogs of the coenzyme. Eur J Biochem (1972) 0.89
Quasiparticlelike peaks, kinks, and electron-phonon coupling at the (pi,0) regions in the CMR oxide La2-2x Sr1+2x Mn2 O7. Phys Rev Lett (2006) 0.88
Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer (1999) 0.88
Thogoto virus matrix protein is encoded by a spliced mRNA. J Virol (2000) 0.88
Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. J Biol Chem (1994) 0.88
Immune response in progressive multifocal leukoencephalopathy: an overview. J Neurovirol (2001) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinoma. Br J Dermatol (2005) 0.87
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg (2001) 0.87
Alpha-tocopherol is secreted from rat liver in very low density lipoproteins. J Lipid Res (1988) 0.86
Behaviour of glibenclamide on repeated administration to diabetic patients. Eur J Clin Pharmacol (1977) 0.86
Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci Lett (1998) 0.86
Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J Neuroimmunol (2000) 0.85
Biochemical mechanisms of vitamin A action. Proc Nutr Soc (1983) 0.85
Purification and properties of a carotene co-oxidizing lipoxygenase from peas. Biochim Biophys Acta (1973) 0.85
Mx1 sensitivity: Batken virus is an orthomyxovirus closely related to Dhori virus. J Gen Virol (1997) 0.85
The synchronous occurrence of aspergillosis and myospherulosis of the maxillary sinus. Report of a case with review of the literature. Oral Surg Oral Med Oral Pathol (1987) 0.85
High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol (1999) 0.85
Uptake and release of [I-14C]ascorbic acid and [I-14C]dehydroascorbic acid by erythrocytes of guinea pigs. Clin Chim Acta (1971) 0.85
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients. Acta Neurol Scand (2014) 0.85
[Management of paediatric fever: is parents' skill appropriate?]. Arch Pediatr (2007) 0.85
[Management of indoor air pollution by polychlorinated biphenyl compounds exemplified by two Hagen schools]. Gesundheitswesen (1994) 0.84
Brain volume and diffusion markers as predictors of disability and short-term disease evolution in multiple sclerosis. AJNR Am J Neuroradiol (2012) 0.84